医学
心脏病学
内科学
肌痛
血压
肥厚性心肌病
外围设备
骨骼肌
梗阻性心肌病
心肌病
心力衰竭
肌球蛋白
作者
Mengling Peng,Yu Fu,Cong Qin,Shanshan Zhou,Jian Sun
标识
DOI:10.3389/fcvm.2025.1578356
摘要
Background: Mavacamten has been demonstrated to be effective in the treatment of hypertrophic obstructive cardiomyopathy (HOCM). However, its hemodynamic impact and extracardiac effects require further characterization. Case presentation: We report a case of a 68-year-old female diagnosed with severe HOCM who experienced transient hypertension (165/105 mmHg) and myalgia four weeks after mavacamten initiation. Despite a significant reduction in LVOT obstruction (from 64 mmHg-18 mmHg) and an increase in LVEF to 78%, the patient exhibited a transient hypertensive response that resolved spontaneously within two weeks without intervention. Myalgia was present without corresponding elevations in serum creatine kinase. Conclusions: This case highlights a previously unrecognized transient hypertensive phase associated with myosin inhibition, potentially related to ventriculo-arterial decoupling and peripheral vascular adaptation. Additionally, the dissociation between myalgia and CK elevation suggests alternative skeletal muscle involvement mechanisms. Close blood pressure monitoring and further investigation into the extracardiac effects of mavacamten are warranted.
科研通智能强力驱动
Strongly Powered by AbleSci AI